bioAffinity Technologies, Inc. Common Stock BIAF
$10.45
+58.60%
at last close
Financials (TTM)
- Revenue
- $5.90 million
- Net Income
- $-15,185,242
- Net Margin
- -257.33%
- Return on Equity
- -402.92%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.04
- Price / Sales
- 0.66
Over the trailing twelve months, bioAffinity Technologies, Inc. Common Stock generated revenue of $5.90 million and net income of $-15,185,242, a net margin of -257.33%.
At the last closing price of $10.45, BIAF trades at 0.66 times sales, with a market capitalization of $3.90 million.
Key Stats
- Last Close
- $10.45
- Market Cap
- $3.90 million
- 52-Week Range
- $4.56 – $202.50
- Average Volume
- 3.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.